{
    "ucits": true,
    "type": "ETF",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication, Derivatives, Inverse exposure, Daily reset compounding, Structured strategy",
    "classification": "complex",
    "supporting_data": "The product is a WisdomTree FTSE 100 2x Daily Short ETP, which is UCITS eligible but structured as a leveraged inverse product providing -2 times daily exposure to the FTSE 100 index. It uses derivatives (futures contracts and swaps) to achieve this synthetic replication and leverage. The daily reset of leverage introduces compounding effects that make the return over periods longer than one day deviate significantly from the simple leveraged index return. The product is described as a collateralised debt security, not a physical ETF holding underlying securities, indicating synthetic replication. The use of leverage beyond UCITS limits (2x leverage here) and inverse exposure are features that increase complexity. The product targets informed retail investors with specific knowledge or experience, acknowledging the complexity. The risk indicator is at the highest level (7/7), reflecting high risk and complexity. According to MiFID II Article 254, Delegated Regulation EU 2017/565 Article 57, and ESMA guidelines, such features (leverage, synthetic replication, derivatives integral to strategy, inverse exposure, and complex payoff structures) classify the product as complex. UCITS status alone does not override complexity if the ETF invests in derivatives or structured products with embedded derivatives or leverage. Therefore, this ETF is complex under MiFID II and requires an appropriateness assessment for retail investors before sale on a non-advised basis."
}